Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2359-2366

  Shemyakin, Alexey ^a   Salehzadeh, Firoozeh ^a   Böhm, Felix ^a   Al Khalili, Lubna ^a   Gonon, Adrian ^a   Wagner, Henrik ^a   Efendic, Suad ^a   Krook, Anna ^a   Pernow, John ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; GLUCOSE; INSULIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; C REACTIVE PROTEIN; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; GLYCOSYLATED HEMOGLOBIN; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; FOREARM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INSULIN METABOLISM; INSULIN RESISTANCE; MALE; MOLECULAR BIOLOGY; MUSCLE CELL; PRIORITY JOURNAL; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; BLOOD; BLOOD FLOW; BODY MASS; GLUCOSE BLOOD LEVEL; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; VASCULARIZATION;

BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BODY MASS INDEX; BRACHIAL ARTERY; C-REACTIVE PROTEIN; ENDOTHELIN-1; FOREARM; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; REGIONAL BLOOD FLOW; TRIGLYCERIDES;

EID: 77952782668     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1506     Document Type: Article

References (33)

1. Reaven GM 1993 Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121-131 (Pubitemid 23117853)
2. Böhm F, Pernow J 2007 The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76:8-18
3. Jansson PA 2007 Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 262:173-183
4. Muniyappa R, Montagnani M, Koh KK, Quon MJ 2007 Cardiovascular actions of insulin. Endocr Rev 28:463-491
5. Jiang ZY, Zhou QL, Chatterjee A, Feener EP, Myers Jr MG, White MF, King GL 1999 Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinasepathwayin vascular smooth muscle cells. Diabetes 48:1120-1130
6. Strawbridge AB, Elmendorf JS 2005 Phosphatidylinositol 4,5-bisphosphate reverses endothelin-1-induced insulin resistance via an actin-dependent mechanism. Diabetes 54:1698-1705
7. Strawbridge AB, Elmendorf JS 2006 Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism. J Cell Biochem 97:849-856
8. Ahlborg G, Weitzberg E, Lundberg JM 1994 Endothelin-1 infusion reduces splanchnic glucose production in humans. J Appl Physiol 77:121-126 (Pubitemid 24226123)
9. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G 1997 Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 161:211-220
10. Ahlborg G, Shemyakin A, Böhm F, Gonon A, Pernow J 2007 Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease. Diabetes Care 30:591-596
11. Lteif A, Vaishnava P, Baron AD, Mather KJ 2007 Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes 56:728-734
12. Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I 2006 Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 114:249-256
13. Böhm F, Ahlborg G, Pernow J 2002 Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin Sci (Lond) 102:321-327
14. Hemsén A, Ahlborg G, Ottosson-Seeberger A, Lundberg JM 1995 Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept 55:287-297
15. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, Ehrenborg E, Ding VD, Zierath JR, Krook A 2003 Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 60:991-998
16. Wheatcroft SB, Williams IL, Shah AM, Kearney MT 2003 Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20:255-268
17. Rask-Madsen C, Domínguez H, Ihlemann N, Hermann T, Køber L, Torp-Pedersen C 2003 Tumor necrosis factor-α inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108:1815-1821
18. Ahlborg G, Lindström J 2002 Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans. J Appl Physiol 93:2112-2121
19. Wilkes JJ, Hevener A, Olefsky J 2003 Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes 52:1904-1909
20. Cardillo C, Campia U, Bryant MB, Panza JA 2002 Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106:1783-1787
21. Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G 1995 Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 18:226-233
22. Shemyakin A, Böhm F, Wagner H, Efendic S, Båvenholm P, Pernow J 2006 Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance. J Cardiovasc Pharmacol 47:385-390
23. Kolka CM, Rattigan S, Richards S, Clark MG 2005 Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle. Br J Pharmacol 145:992-1000
24. Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM 2001 Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J Clin Invest 107:1193-1202 (Pubitemid 32422916)
25. Kohn AD, Summers SA, Birnbaum MJ, Roth RA 1996 Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-31378
26. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE 2008 IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7:421-433
27. Randhawa VK, Ishikura S, Talior-Volodarsky I, Cheng AW, Patel N, Hartwig JH, Klip A 2008 GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells. J Biol Chem 283:27208-27219
28. Yip MF, Ramm G, Larance M, Hoehn KL, Wagner MC, Guilhaus M, James DE 2008 CaMKII-mediated phosphorylation of the myosin motor Myo1c is required for insulin-stimulated GLUT4 translocation in adipocytes. Cell Metab 8:384-398
29. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A 1995 Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 92:2911-2918
30. Cardillo C, Kilcoyne CM, Nambi SS, Cannon 3rd RO, Quon MJ, Panza JA 1998 Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension 32:740-745
31. Verma S, Yao L, Stewart DJ, Dumont AS, Anderson TJ, McNeill JH 2001 Endothelin antagonism uncovers insulin-mediated vasorelaxation in vitro and in vivo. Hypertension 37:328-333
32. Miller AW, Tulbert C, Puskar M, Busija DW 2002 Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance. Hypertension 40:78-82
33. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD 1994 Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179 (Pubitemid 24286460)